Huntington National Bank Grows Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Huntington National Bank raised its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 34.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,245 shares of the real estate investment trust’s stock after buying an additional 1,607 shares during the period. Huntington National Bank’s holdings in Omega Healthcare Investors were worth $254,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Versant Capital Management Inc acquired a new position in Omega Healthcare Investors during the second quarter worth $26,000. UMB Bank n.a. raised its stake in shares of Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 516 shares during the last quarter. DiNuzzo Private Wealth Inc. purchased a new stake in shares of Omega Healthcare Investors in the 3rd quarter worth about $33,000. V Square Quantitative Management LLC grew its stake in Omega Healthcare Investors by 49.5% in the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after acquiring an additional 323 shares during the last quarter. Finally, Covestor Ltd increased its holdings in Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after acquiring an additional 431 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Omega Healthcare Investors Trading Up 0.7 %

Shares of OHI stock opened at $40.03 on Friday. The firm’s 50-day simple moving average is $40.66 and its 200-day simple moving average is $36.66. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42. The firm has a market cap of $10.81 billion, a P/E ratio of 29.43, a PEG ratio of 1.25 and a beta of 0.99.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.69%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 197.06%.

Analyst Ratings Changes

Several analysts have issued reports on OHI shares. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 target price on the stock. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 price target (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. Finally, Scotiabank boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.